Clinical trial
A One Arm, Open-label Study to Investigate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients Who Received Mycophenolate Mofetil (MMF)
NCT00238966 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A One Arm, Open-label Study to Investigate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Recipients Who Received Mycophenolate Mofetil (MMF)
- Lead sponsor
- Novartis
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2002
- Completion date
- April 30, 2005
- Enrollment
- 187 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
renal transplantation